Multiple "step-sections" are prepared for many diagnostic biopsies, but tissue is usually left in the block for possible additional studies. We sought to determine the frequency with which sampling the remaining tissue with additional step-sections would reveal pathologic abnormality in a series of colorectal biopsies originally diagnosed as normal. Slides of 232 cases were reviewed and classified into 7 standard diagnostic categories. Review of the original 3 slides showed pathologic abnormality to actually be present in 9 cases (3.9%). The additional step-sections revealed pathologic abnormality in 4 (1.7%) other cases, as follows: tubular adenoma, 3 cases; lymphocytic colitis, 1 case. Neither previous nor concurrent clinical or pathological information related to colorectal disease identified the cases that were more likely to yield diagnostic abnormality in the additional step-sections. However, there was a statistically nonsignificant trend for specimens with a clinical diagnosis of "polyp" to display tubular adenoma in the deeper sections. Because examination of remaining tissue yielded new diagnostic information less frequently than the observed rate of diagnostic error, reduction in interobserver error may be a more fruitful strategy for obtaining a correct diagnosis than would complete histologic sampling.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.humpath.2007.08.015 | DOI Listing |
Rom J Morphol Embryol
November 2022
Discipline of Management, Legislation and Communication in Dental Medicine, Faculty of Dental Medicine, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania; Department of Dental Medicine, Faculty of Medicine and Pharmacy, University of Oradea, Romania;
Breast cancer (BrCa) is the most frequent malignancy in female, and lymph node metastases (LNM) is an important prognostic and therapeutic parameter. The molecular classification is nowadays largely applied to characterize the primary tumors, but few studies focused on the comparison between the molecular profiles of the primary with corresponding LNM. In the current work, we investigated the expression of conventional markers used by molecular classification in both primary tumors and axillary LNM.
View Article and Find Full Text PDFVet Pathol
September 2022
Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Lymph node (LN) metastasis in canine mast cell tumor (MCT) can affect prognosis and postsurgical treatment recommendations; however, routine histological single-section examination may underestimate the incidence of metastases. This prospective study aimed at determining whether longitudinal step-sectioning of the entire LN allows for a more reliable detection of metastases. Dogs with MCT undergoing resection of the primary tumor and regional lymphadenectomy were enrolled.
View Article and Find Full Text PDFRegul Toxicol Pharmacol
July 2019
Havlik-Wall Professor of Oncology, Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135, Omaha, NE, 68198-3135, USA.
The carcinogenic potential of a non-genotoxic pyrethroid imiprothrin was examined in rats and mice. There was no carcinogenicity in rats up to a maximum dose of 5000 ppm of the diet. There was a higher (p = 0.
View Article and Find Full Text PDFMod Pathol
January 2018
Institute of Pathology of the University Hospital Bonn, Bonn, Germany.
Molecular diagnostics is a rapidly evolving area of surgical pathology, that is gradually beginning to transform our diagnostical procedures for a variety of tumors. Next to molecular prognostication that has begun to complement our histological diagnosis in breast cancer, additional testing to detect targets and to predict therapy response has become common practice in breast and lung cancer. Prostate cancer is a bit slower in this respect, as it is still largely diagnosed and classified on morphological grounds.
View Article and Find Full Text PDFTech Coloproctol
September 2017
Department of Gastroenterology, Cancer Institute, University of Sao Paulo, São Paulo, Brazil.
Background: Neoadjuvant chemoradiation therapy (nCRT) for rectal cancer may lead to cure. As we currently lack reliable methods to clinically confirm the absence of disease, some patients undergo radical resection and have pathological complete response (pCR) still undergo surgery. Furthermore, it is uncertain if conventional one-level histopathological analysis is accurate enough to determine complete response.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!